Most Detailed Prostate Cancer Cell Atlas Yet Charts Earliest Disease Signals
The map hints at earlier detection through molecular tests pending larger studies.
Overview
- Garvan Institute researchers, whose study appeared Wednesday in Cancer Research, unveiled a high‑resolution single‑cell and spatial map of early, treatment‑naïve prostate cancer.
- The atlas shows many cells that look normal under a microscope already carry DNA changes linked to cancer, exposing a blind spot in standard pathology reviews.
- Using biopsies from 24 newly diagnosed patients, the team applied single‑cell RNA sequencing and spatial transcriptomics to map 11 major cell types and about 50 subtypes.
- Scientists identified a new population called perineural cancer‑associated fibroblasts clustered near nerves, a site long tied to poorer outcomes in prostate tumors.
- Researchers plan larger cohorts and functional follow‑ups to test clinical value for earlier detection, with any patient‑facing use still years away.